These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3758141)

  • 21. [Use of aldactone-saltucine in patients with heart failure].
    Bobkova VI; Kartitskií VS; Lapkes TG; Mazurova SV
    Kardiologiia; 1975 May; 15(5):105-8. PubMed ID: 1152318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of mefruside on plasma and muscle electrolytes and blood pressure in normal subjects and in patients with essential hypertension.
    Bergström J; Hultman E; Solheim SB
    Acta Med Scand; 1973 Nov; 194(5):427-33. PubMed ID: 4757222
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of aldactone-saltucine for patients with chronic circulatory insufficiency].
    Sidorenko BA; Savenkov PM; Kharchenko VI; Evsikov EM
    Kardiologiia; 1975 May; 15(5):108-14. PubMed ID: 1152319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total-body potassium in hypertension patients during prolonged diuretic therapy.
    Edmonds CJ; Jasani B
    Lancet; 1972 Jul; 2(7766):8-12. PubMed ID: 4113653
    [No Abstract]   [Full Text] [Related]  

  • 26. Potassium-sparing diuretics.
    Dyckner T; Wester PO
    Acta Med Scand Suppl; 1986; 707():79-83. PubMed ID: 3461689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short- and long-term mechanisms of sudden cardiac death in congestive heart failure.
    Helfant RH
    Am J Cardiol; 1990 Jun; 65(23):41K-43K. PubMed ID: 2353668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
    Liu C; Liu G; Zhou C; Ji Z; Zhen Y; Liu K
    Can J Cardiol; 2007 Sep; 23(11):865-8. PubMed ID: 17876376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
    Barr CS; Lang CC; Hanson J; Arnott M; Kennedy N; Struthers AD
    Am J Cardiol; 1995 Dec; 76(17):1259-65. PubMed ID: 7503007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension.
    Cleland JG; Dargie HJ; Robertson I; Robertson JI; East BW
    Br Heart J; 1987 Sep; 58(3):230-8. PubMed ID: 3311097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects on muscle electrolytes of potassium and magnesium infusions, spironolactone medication and operation in a case of primary aldosteronism.
    Dyckner T; Wester PO
    Acta Med Scand; 1979; 206(1-2):137-40. PubMed ID: 484255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of magnesium infusions in diuretic induced hyponatraemia.
    Dyckner T; Wester PO
    Lancet; 1981 Mar; 1(8220 Pt 1):585-6. PubMed ID: 6110822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K(+) depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion.
    Laragh JH; Sealey JE
    Hypertension; 2001 Feb; 37(2 Pt 2):806-10. PubMed ID: 11230377
    [No Abstract]   [Full Text] [Related]  

  • 38. Spironolactone in the long-term management of patients with congestive heart failure.
    Smith AG
    Curr Med Res Opin; 1980; 7(2):131-6. PubMed ID: 7438770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretics in congestive heart failure: new evidence for old problems.
    Haller C
    Nephrol Dial Transplant; 1999 Jun; 14(6):1358-60. PubMed ID: 10382992
    [No Abstract]   [Full Text] [Related]  

  • 40. Heart failure and electrolyte disturbances.
    Schwinger RH; Erdmann E
    Methods Find Exp Clin Pharmacol; 1992 May; 14(4):315-25. PubMed ID: 1507935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.